SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
94 hedge funds and large institutions have $538M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 19 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
4% less capital invested
Capital invested by funds: $560M → $538M (-$21.7M)
5% less funds holding
Funds holding: 99 → 94 (-5)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$25.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.1M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$7.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$12.9M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$12.8M |
| 3 |
Jennison Associates
New York
|
-$11M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.27M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.15M |
SGNT Hedge Fund Activity: Q1 2014 in Review
94 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q1 2014, worth a combined $538M — down 3.9% from $560M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of SGNT and 14 opened new positions — a net loss of 5 holders — while 32 trimmed existing stakes and 38 added.
The largest buyer was Franklin Resources, adding an estimated $25.8M. The largest seller was Loomis, Sayles & Company, exiting entirely with an estimated $12.9M sold.
- 94 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q1 2014, down from 99 in Q4 2013.
- Funds reported $538M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q1 2014, down 3.9% quarter-over-quarter.
- 14 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q1 2014 and 19 closed out, a net change of -5 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q1 2014 was Franklin Resources, an estimated $25.8M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q1 2014 was Loomis, Sayles & Company, an estimated $12.9M sold.
Based on aggregated 13F filings for Q1 2014.